A detailed history of Charter Oak Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Charter Oak Capital Management, LLC holds 12,455 shares of PFE stock, worth $347,868. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,455
Previous 12,505 0.4%
Holding current value
$347,868
Previous $360,000 4.17%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $1,294 - $1,486
-50 Reduced 0.4%
12,455 $345,000
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $26,417 - $34,313
1,011 Added 8.8%
12,505 $360,000
Q3 2023

Oct 04, 2023

SELL
$32.09 - $37.51 $4,973 - $5,814
-155 Reduced 1.33%
11,494 $381,000
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $23,369 - $27,038
647 Added 5.88%
11,649 $427,000
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $32,457 - $42,254
824 Added 8.1%
11,002 $448,000
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $19,914 - $25,996
-477 Reduced 4.48%
10,178 $0
Q3 2022

Dec 06, 2022

SELL
$43.76 - $53.42 $306 - $373
-7 Reduced 0.07%
10,655 $466,000
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $24,893 - $29,515
-535 Reduced 4.78%
10,662 $559,000
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $594 - $736
13 Added 0.12%
11,197 $580,000
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $702 - $1,041
17 Added 0.15%
11,184 $660,000
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $125,011 - $160,587
3,185 Added 39.9%
11,167 $480,000
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $2,585 - $2,928
72 Added 0.91%
7,982 $313,000
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $1,674 - $1,888
50 Added 0.64%
7,910 $287,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $263,074 - $334,521
7,860 New
7,860 $289,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Charter Oak Capital Management, LLC Portfolio

Follow Charter Oak Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Charter Oak Capital Management, LLC with notifications on news.